Mediaplanet Joins CardioComm Solutions in Fighting Heart Disease with "Cardiovascular Health" Campaign
Mediaplanet today announces the distribution of its third cross-platform edition of "Cardiovascular Health" that will be distributed nationally in print and online.
(PRWEB) March 25, 2016
With the heightened advocacy for cardiovascular disease in the month of February, aims to hereby continue that discussion into the following months. In collaboration with the American College of Cardiology, American Heart Association, CardioComm Solutions and many more, this "Cardiovascular Health" campaign will educate the millions living with some form of this disease about management and treatment options, so they can take control of their condition.
The print component of "Cardiovascular Health" is distributed within this Friday's edition of USA Today, with a circulation of approximately 450,000 copies and an estimated readership of 1.3 million. The digital component is distributed nationally, through a vast social media strategy, and across a network of top news sites and partner outlets. To export the digital version of the campaign, click here.
This campaign was made possible with support from CardioComm Solutions, Inc., which specializes in electrocardiogram (ECG) management and reporting software. The HeartCheck™ ECG PEN, a diagnostic tool that records the electrical functions of the heart. It is used to take a 30 second ECG recording to monitor for the presence or absence of an arrhythmia. The recorded ECGs are to be uploaded to CardioComm Solutions' managed cloud SMART Monitoring ECG service where the Company's proprietary and FDA cleared ECG software is used to review and provide ECG interpreted reports back to PEN users. An advantage of the HeartCheck™ ECG PEN is that it cleared by the FDA as a medical device for consumer use, it is small and fully contained ECG device that can independently record, save, replay and transfer recorded ECGs to a computer. A market advantage of the HeartCheck™ ECG PEN over other ECG monitors is that in addition to the usual handheld recordings (Lead I), the device can be held in the right hand and pressed against the left side of the chest or ribs to record a Lead II ECG, which is preferred by physicians when screening for arrhythmias. With this device, arrhythmias can be detected anywhere.
About CardioComm Solutions
CardioComm Solutions' patented and proprietary technology is used in products for recording, viewing, analyzing and storing electrocardiograms (ECGs) for diagnosis and management of cardiac patients. Products are sold worldwide through a combination of an external distribution network and a North American-based sales team. The Company has earned the ISO 13485 certification, is HPB approved, HIPAA compliant, and has received FDA market clearance for its software devices. CardioComm Solutions is headquartered in Toronto, Ontario, Canada. CardioComm Solutions HeartCheck™ ECG devices and GEMS™ based software platforms have been met required clearance as approvals from the FDA, Health Canada and the European Union (CE Mark)
Mediaplanet is the leading independent publisher of content-marketing campaigns covering a variety of topics and industries. We turn consumer interest into action by providing readers with motivational editorial, pairing it with relevant advertisers and distributing it within top newspapers and online platforms around the world.
For the original version on PRWeb visit: http://www.prweb.com/releases/2016/03/prweb13294723.htmView Comments and Join the Discussion!